BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 36398743)

  • 1. High-risk human papillomavirus genotype distribution among women living with and at risk for HIV in Africa.
    Chachage M; Parikh AP; Mahenge A; Bahemana E; Mnkai J; Mbuya W; Mcharo R; Maganga L; Mwamwaja J; Gervas R; Kibuuka H; Maswai J; Singoei V; Iroezindu M; Fasina A; Esber A; Dear N; Imbach M; Crowell TA; Hern J; Song X; Hoelscher M; Polyak CS; Ake JA; Geldmacher C;
    AIDS; 2023 Mar; 37(4):625-635. PubMed ID: 36398743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and distribution of cervical high-risk human papillomavirus and cytological abnormalities in women living with HIV in Denmark - the SHADE.
    Thorsteinsson K; Storgaard M; Katzenstein TL; Ladelund S; Rønsholt FF; Johansen IS; Pedersen G; Hashemi L; Nielsen LN; Nilas L; Obel N; Bonde J; Lebech AM
    BMC Cancer; 2016 Nov; 16(1):866. PubMed ID: 27821088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple High-Risk HPV Types Contribute to Cervical Dysplasia in Ugandan Women Living With HIV on Antiretroviral Therapy.
    Nakisige C; Adams SV; Namirembe C; Okoche L; Ferrenberg J; Towlerton A; Larsen A; Orem J; Casper C; Frenkel L; Uldrick TS
    J Acquir Immune Defic Syndr; 2022 Jul; 90(3):333-342. PubMed ID: 35195571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of high-risk human papillomavirus infections and associated cervical dysplasia in HIV-positive pregnant women in Germany: a prospective cross-sectional two-centre study.
    Metz CK; Skof AS; Sehouli J; Siedentopf JP; Gebert P; Weiss F; Alba Alejandre I; Heinrich-Rohr M; Weizsaecker K; Henrich W; Kaufmann AM; Rohr I
    Arch Gynecol Obstet; 2023 Jul; 308(1):207-218. PubMed ID: 36576558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of HPV subtypes in invasive cervical cancer in Botswana patients using a pan-pathogen microarray technology.
    Grover S; Seckar T; Gao L; Bhatia R; Lin X; Zetola N; Ramogola-Masire D; Robertson E
    Tumour Virus Res; 2023 Jun; 15():200262. PubMed ID: 37209888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of Multiplex Polymerase Chain Reaction for Detection of High-Risk Human Papillomavirus Genotypes in Women Attending Routine Cervical Cancer Screening in Harare.
    Marembo T; Dube Mandishora R; Borok M
    Intervirology; 2019; 62(2):90-95. PubMed ID: 31412350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of cervical, oral, and anal human papillomavirus infection in women living with HIV in Denmark - The SHADE cohort study.
    Thorsteinsson K; Storgaard M; Katzenstein TL; Ladelund S; Rönsholt FF; Johansen IS; Pedersen G; Gaardsting A; Nielsen LN; Bonde J; Lebech AM
    J Clin Virol; 2018 Aug; 105():64-71. PubMed ID: 29906660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic review of the association between smoking exposure and HPV-related cervical cell abnormality among women living with HIV: Implications for prevention strategies.
    Zhao R; Sekar P; Bennis SL; Kulasingam S
    Prev Med; 2023 May; 170():107494. PubMed ID: 37001607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HPV genotyping in biopsies of HSIL and invasive cervical cancers in women living with HIV: A cohort- and a nested -case control study.
    Gilles C; Rozenberg S; Buxant F; Manigart Y; de Wind R; Houte KV; Vandenbroeck D; Delforge M; Konopnicki D
    Vaccine; 2022 Nov; 40(50):7230-7237. PubMed ID: 36328880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistence of cervical high-risk human papillomavirus in women living with HIV in Denmark - the SHADE.
    Thorsteinsson K; Ladelund S; Storgaard M; Katzenstein TL; Johansen IS; Pedersen G; Rönsholt FF; Nielsen LN; Nilas L; Franzmann M; Obel N; Lebech AM; Bonde J
    BMC Infect Dis; 2019 Aug; 19(1):740. PubMed ID: 31438877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cervical human papillomavirus DNA detection in women living with HIV and HIV-uninfected women living in Limbe, Cameroon.
    Adedimeji A; Ajeh R; Dzudie A; Kendowo E; Fuhngwa N; Nsame D; Simo-Wambo AG; Orock E; Hebert TM; Pierz AJ; Murokora D; Anastos K; Castle PE
    J Clin Virol; 2020 Jul; 128():104445. PubMed ID: 32470891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High Prevalence of Cervical High-Grade Lesions and High-Risk Human Papillomavirus Infections in Women Living with HIV: A Case for Prioritizing Cervical Screening in This Vulnerable Group.
    Gupta R; Hussain S; Hariprasad R; Dhanasekaran K; Verma S; Agarwal V; Sandeep ; Parveen S; Kaur A; Verma CP; Amita ; Dwivedi R; Singh S; Gupta S
    Acta Cytol; 2022; 66(6):496-506. PubMed ID: 35760059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonvaccine human papillomavirus genotype common in women with HIV failing cervical precancer treatment.
    Carlander C; Lagheden C; Eklund C; Nordqvist Kleppe S; Dzabic M; Wagner P; Sparén P; Dillner J
    AIDS; 2021 Nov; 35(14):2367-2374. PubMed ID: 34723851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of genital high-risk human papillomavirus infections and associated factors among women living with human immunodeficiency virus in Uganda.
    Nakigozi H; Ndejjo R; Bazeyo W; Nabaggala A; Achola C; Iga M; Kalyesubula S; Kanamwangi B; Mutungi G; Batte C; Mukunya D; Sserwanga L; Gemageine G; Oyoo CA; Nabadda S
    BMC Cancer; 2024 Feb; 24(1):243. PubMed ID: 38383366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papillomavirus genotype distribution among women with and without cervical cancer: Implication for vaccination and screening in Ghana.
    Nartey Y; Amo-Antwi K; Hill PC; Dassah ET; Asmah RH; Nyarko KM; Agambire R; Konney TO; Yarney J; Damale N; Cox B
    PLoS One; 2023; 18(1):e0280437. PubMed ID: 36656844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Re-valuation of annual cytology using HPV self-sampling to upgrade prevention (REACH UP): A feasibility study in women living with HIV in the UK.
    Cicconi P; Wells C; McCarthy B; Wareing S; Andersson MI; Fox J; Lwanga J; Pal N; Burns F; Woodward C; Malek R; Sabin CA; Dorrell L
    HIV Med; 2022 Apr; 23(4):390-396. PubMed ID: 35243750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The vaginal microbiota of women living with HIV on suppressive antiretroviral therapy and its relation to high-risk human papillomavirus infection.
    Chávez-Torres M; Gómez-Palacio-Schjetnan M; Reyes-Terán G; Briceño O; Ávila-Ríos S; Romero-Mora KA; Pinto-Cardoso S
    BMC Microbiol; 2023 Jan; 23(1):21. PubMed ID: 36658503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of high-risk human papillomavirus and cervical lesions in African women living with HIV/AIDS: effect of anti-retroviral therapy.
    Kelly HA; Sawadogo B; Chikandiwa A; Segondy M; Gilham C; Lompo O; Omar T; Didelot MN; Nagot N; Meda N; Weiss HA; Delany-Moretlwe S; Mayaud P;
    AIDS; 2017 Jan; 31(2):273-285. PubMed ID: 27755107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High risk human papillomavirus prevalence and genotype distribution among women infected with HIV in Manaus, Amazonas.
    Teixeira MF; Sabidó M; Leturiondo AL; de Oliveira Ferreira C; Torres KL; Benzaken AS
    Virol J; 2018 Feb; 15(1):36. PubMed ID: 29454382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology of HPV Genotypes among HIV Positive Women in Kenya: A Systematic Review and Meta-Analysis.
    Menon S; Wusiman A; Boily MC; Kariisa M; Mabeya H; Luchters S; Forland F; Rossi R; Callens S; Vanden Broeck D
    PLoS One; 2016; 11(10):e0163965. PubMed ID: 27764092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.